Jeffrey Schwaneke A.'s most recent trade in Agilon Health Inc was a trade of 46,099 Common Stock done at an average price of $2.4 . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Agilon Health Inc | Jeffrey Schwaneke A. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.38 per share. | 01 Jul 2025 | 46,099 | 1,075,122 | - | 2.4 | 109,716 | Common Stock |
| Agilon Health Inc | Jeffrey A. Schwaneke | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.35 per share. | 28 May 2025 | 9,331 | 1,121,221 | - | 2.4 | 21,928 | Common Stock |
| Agilon Health Inc | Jeffrey A. Schwaneke | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 377,074 | 441,124 | - | 0 | Common Stock | |
| Agilon Health Inc | Jeffrey A. Schwaneke | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 239,072 | 239,072 | - | - | Options (Rights to Buy) | |
| Agilon Health Inc | Jeffrey A. Schwaneke | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 150,830 | 723,930 | - | 0 | Common Stock | |
| Agilon Health Inc | Jeffrey A. Schwaneke | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 131,976 | 573,100 | - | 0 | Common Stock | |
| Agilon Health Inc | Jeffrey A. Schwaneke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 32,119 | 64,050 | - | 0 | Common Stock | |
| Agilon Health Inc | Jeffrey A. Schwaneke | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Nov 2023 | 673,077 | 673,077 | - | - | Options (Right to buy) | |
| Agilon Health Inc | Jeffrey A. Schwaneke | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Nov 2023 | 428,922 | 1,130,552 | - | 0 | Common Stock | |
| Agilon Health Inc | Jeffrey A. Schwaneke | Director | Purchase of securities on an exchange or from another person at price $ 11.22 per share. | 29 Nov 2023 | 22,300 | 31,931 | - | 11.2 | 250,206 | Common Stock |
| Agilon Health Inc | Jeffrey A. Schwaneke | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 11.22 per share. | 29 Nov 2023 | 22,300 | 22,300 | - | 11.2 | 250,206 | Common Stock |
| Agilon Health Inc | Jeffrey A. Schwaneke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 5,622 | 9,631 | - | 0 | Common Stock | |
| Agilon Health Inc | Jeffrey A. Schwaneke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 9,680 | 9,680 | - | - | Options (Rights to Buy) | |
| Agilon Health Inc | Jeffrey A. Schwaneke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 4,009 | 4,009 | - | 0 | Common Stock | |
| Centene | Jeffrey A. Schwaneke | EVP, HealthCare Enterprises | Sale of securities on an exchange or to another person at price $ 69.00 per share. | 07 May 2021 | 18,000 | 454,549 (0%) | 0% | 69 | 1,242,000 | Common Stock |
| Centene | Jeffrey A. Schwaneke | EVP, CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2020 | 2,150 | 472,549 (0%) | 0% | 0 | Common Stock | |
| Centene | Jeffrey A. Schwaneke | EVP, CFO | Grant, award, or other acquisition of securities at price $ 59.73 per share. | 15 Dec 2020 | 90,000 | 474,699 (0%) | 0% | 59.7 | 5,375,700 | Common Stock |
| Centene | Jeffrey A. Schwaneke | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.73 per share. | 15 Dec 2020 | 24,778 | 384,699 (0%) | 0% | 59.7 | 1,479,990 | Common Stock |
| Centene | Jeffrey A. Schwaneke | EVP, CFO | Grant, award, or other acquisition of securities at price $ 49.85 per share. | 15 Dec 2020 | 19,368 | 409,477 (0%) | 0% | 49.9 | 965,495 | Common Stock |
| Centene | Jeffrey A. Schwaneke | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.31 per share. | 10 Dec 2020 | 5,967 | 393,690 (0%) | 0% | 61.3 | 365,837 | Common Stock |
| Centene | Jeffrey A. Schwaneke | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.45 per share. | 10 Dec 2020 | 5,967 | 399,657 (0%) | 0% | 63.4 | 378,606 | Common Stock |
| Centene | Jeffrey A. Schwaneke | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.71 per share. | 10 Dec 2020 | 3,581 | 390,109 (0%) | 0% | 60.7 | 217,403 | Common Stock |